Baroreflex sensitivity is impaired in essential hypertensives with central obesity

Journal of Human Hypertension

Volumn 21, Issue 6, 2007, Pages 473-478

  Del Colle, S ^a   Milan, A ^a   Caserta, M ^a   Dematteis, A ^a   Naso, D ^a   Mulatero, P ^a   Rabbia, F ^a   Veglio, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL FAT; ANALYZER; ANTHROPOMETRY; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; OBESITY; PRESSORECEPTOR REFLEX; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; BAROREFLEX; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 34249284161     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002163     Document Type: Article

References (30)

1. Lantelme P, Khettab F, Custaud MA, Rial MO, Joanny C, Gharib C et al. Spontaneous baroreflex sensitivity: Toward an ideal index of cardiovascular risk in hypertension? J Hypertens 2002; 20: 935-944.
2. La Rovere MT, Bigger Jr JT, Marcus F, Mortara A, Schwartz P. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478-484.
3. Reaven GM. Banting lecture. 1988 role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
5. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: Need to focus on high risk abdominally obese patients. BMJ 2001; 322 716-720.
6. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
7. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106(20): 2533-2536.
8. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: Implications for the metabolic syndrome. Am J Physiol 2002; 282: H630-H635.
9. Brook R, Julius S. Autonomic imbalance, hypertension and cardiovascular risk. Am Heart J 2000; 13: 112(S)-121(S).
10. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. JAMA 2001; 285: 2846-2897.
11. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/ IDF_Metasyndrome_definition.pdf. Accessed August 24, 2004.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of metabolic syndrome An American Heart Association/ National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
13. WHO-ISH Guidelines Subcommittee. 1999 World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
14. Imholz BP, Langewounters GJ, van Montfrans GA, Parati G, van Goudoever J, Wesseling KH. Feasibility of ambulatory, continuous 24 h finger arterial pressure recording. Hypertension 1993; 21: 65-73.
15. Milan A, Mulatero P, Williams TA, Carra R, Schiavone D, Martuzzi R et al. Bradykinin B2 receptor gene (-58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients. J Hypertens 2005; 23: 63-69.
16. Hall JE, Brands MW, Smith Jr MJ. Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension 1993; 22: 292-299.
17. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 886-893.
18. Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street? Hypertension 2000; 35: 807-813.
19. Valentini M, Julius S, Palatini P, Brook RD, Bard RL, Bisognano JD. Attenuation of hemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004; 22: 1999-2006.
20. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 1999; 33(5): 698-702.
21. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith Jr MJ. Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 1995; 269(Part 2): H629-H637.
22. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363-2369.
23. Lucini D, Cusumano G, Bellia A, Kozakova M, Di Fede G, Lauro R, et al., for the Linosa Study Group. Is reduced baroreflex gain a component of the metabolic syndrome? Insight from the Linosa Study. J Hypertens 2006; 24(2): 361-370.
24. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: Retrospective study. BMJ 2005; 330: 1363-1364.
25. Despres JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991; 261(Part 1): E59-E67.
26. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with metabolic syndrome. J Clin Endocrinol Metab 2005; 9: 22-27.
27. Parati G, Frattola A, Di Rienzo M. Effects of aging on 24 hr dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995; 268: H1606-H1612.
28. Christou DD, Jones PP, Pimentel AE, Seals DR. Increased abdominal to peripheral fat distribution contributes to altered autonomic-circulatory control with human aging. Am J Physiol Heart Circ Physiol 2004; 287: H1530-H1537.
29. Julius S. Changing role of autonomic nervous system in hypertension. J Hypertens 1990; 8(7): S59-S65.
30. Mancia G, Mark AL. Arterial baroreflex in hymans. In: Abboud FM, Shepherd JT (eds). Handbook of Physiology, the Cardiovascular System vol. III. American Society of Physiology: Bethesda, Maryland, 1983, pp 755-793.